Explore 3 Stock Ideas & Industry Insights Download Free Report

Change Agents Corporation

Company price
0.9019 USD 0.06 ( 7.36%)
Last update at 2026-11-09T15:48:00Z
VOLUME
2557
Market Cap
1.97M
P/E
0.05

Momentum Score

…

Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026. Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.84
Low
0.94
High
52 Week Price Range
1.93
Low
55.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Change Agents Corporation (NASDAQ: CHGA) is a publicly listed company whose public filings provide limited information about its operations and business model. With scarce disclosed strategy, identifiable long-term growth drivers are unclear and any future growth may depend on successful execution of a defined plan, access to financing, or acquisitions, so investors should monitor forthcoming regulatory filings and press releases.

Key risks include execution and financing risk, thin trading liquidity and share concentration that can amplify price volatility, and regulatory or operational uncertainty given limited public disclosure.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.84
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.10
ROE
-576.07%
Net Debt
0.83M
ROCE
-173.58%
Diluted EPS TTM
39.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.52M -7.04M -16.71M -11.93M -9.09M
Minority interest 0.00M 0.00M 0.00M 0.00M -
Net income -18.26M -7.90M -16.71M -11.93M -9.09M
Selling general administrative 7.14M 3.76M 5.75M 5.66M 8.92M
Selling and marketing expenses 0.84M 0.24M 1.67M 1.33M 0.33M
Gross profit - -0.85M 0.24M 0.27M 1.33M
Reconciled depreciation 0.16M 0.12M 0.33M 0.47M -
Ebit -16.06M -3.99M -15.36M -8.35M -
Ebitda -15.90M -3.87M -15.03M -7.89M -
Depreciation and amortization 0.16M 0.12M 0.33M 0.47M -
Operating income -7.59M -4.84M -7.18M -7.44M -8.83M
Other operating expenses 7.59M 3.99M 8.44M 8.65M 10.16M
Interest expense 1.46M 1.66M 1.35M 3.58M 0.20M
Tax provision 0.00M 0.00M 0.00M 0.00M -
Net interest income -1.46M -1.66M -1.35M -3.58M -
Total revenue 0.00M -0.85M 1.26M 1.20M 1.33M
Total operating expenses 7.59M 3.99M 7.42M 7.72M 10.16M
Cost of revenue - 0.12M 1.02M 0.93M -
Total other income expense net -9.93M -2.20M -9.52M -4.49M -0.26M
Net income from continuing ops -17.52M -7.04M -16.71M -11.93M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 23.40M 20.99M 20.58M 19.75M -
Intangible assets 2.16M - - - -
Other current assets 0.55M 0.06M 0.06M 0.04M -
Total liab 14.17M 13.88M 13.21M 8.59M -
Total stockholder equity 9.23M 7.10M 7.37M 11.16M -
Other current liab 13.15M 6.05M 0.02M - -
Common stock 0.00M - - - -
Capital stock 27.54M 23.50M 20.00M 9.00M -
Retained earnings -105.93M -87.67M -79.77M -63.06M -
Good will 12.81M 0.00M - - -
Cash 0.11M 2.66M 0.29M 1.99M -
Total current liabilities 14.15M 13.88M 6.76M 3.58M -
Net debt 0.83M 4.97M 8.09M 2.57M -
Short term debt 0.94M - - - -
Short long term debt 0.93M 2.11M 1.93M - -
Short long term debt total 0.94M - - - -
Other stockholder equity 87.85M - - - -
Total current assets 1.50M 3.24M 0.85M 2.37M -
Long term investments 0.00M 10.64M 12.10M 0.49M -
Net receivables 0.76M 0.00M 0.20M 0.13M -
Long term debt - - 6.45M 4.56M -
Inventory 0.07M 0.09M 0.00M - -
Accumulated other comprehensive income -0.23M - - - -
Non currrent assets other 6.94M 7.11M 0.28M 0.38M -
Non current assets total 21.90M 17.75M 19.73M 17.38M -
Capital lease obligations 0.01M 0.01M 0.13M 0.01M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities 1.05M -0.10M -0.02M -9.05M -0.07M
Net borrowings 0.50M -0.42M 4.12M 7.82M -
Total cash from financing activities 1.40M 7.64M 4.83M 17.26M 5.17M
Net income -17.52M -7.04M -16.71M -11.93M -9.09M
Change in cash -2.55M 2.58M -1.71M 1.18M 0.08M
Begin period cash flow 2.66M 0.08M 1.99M 0.81M 0.73M
End period cash flow 0.11M 2.66M 0.29M 1.99M 0.81M
Total cash from operating activities -4.99M -4.96M -6.50M -7.04M -5.02M
Issuance of capital stock 0.78M 6.36M 0.64M 9.74M -
Depreciation 0.16M 0.12M 0.33M 0.47M 0.44M
Other cashflows from investing activities -0.04M - - -9.00M -0.07M
Change to account receivables - 0.13M -0.05M -0.04M -0.03M
Other cashflows from financing activities 0.43M 5.20M 0.07M 8.71M 2.62M
Capital expenditures 0.00M 0.00M 0.02M 9.00M 0.00M
Change in working capital 1.68M -1.45M -0.04M 0.21M 1.50M
Stock based compensation 1.82M 0.52M 1.18M 1.11M 2.11M
Other non cash items 8.87M 2.89M 8.73M 3.11M 0.02M
Free cash flow -4.99M -4.96M -6.53M -16.04M -5.02M

Peer Comparison*

Sector: Real Estate Industry: Real Estate Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CHGA
Change Agents Corporation
0.06
7.36%
0.90 0.05 - - 7.51 17.05 -4.45
CBRE
CBRE Group Inc Class A
3.26
2.41%
138.77 38.92 21.37 1.09 4.95 1.28 25.73
BEKE
Ke Holdings Inc
-0.52
2.73%
18.34 42.90 16.92 0.33 2.33 1.66 24.07
VNNVF
Vonovia SE
-
-%
18.44 - 13.44 3.96 0.83 4.07 -3.05
VTAGY
Vantage Towers AG
-
-%
21.42 42.00 37.59 28.32 3.61 21.19 24.26

Profile*

Change Agents Corporation

Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026. Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.

4400 Route 9 South, Freehold, NJ, United States, 07728

732 780 4400

2

Name Title Year Born
Ms. Meng Li Interim CEO, COO & Secretary 1978
Ms. Luisa Ingargiola Chief Strategy Officer 1967
Mr. Samuel J. Knipper Chief Financial Officer 1995

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…